Search Results - Chris Verslype

Refine Results
  1. 1
    Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Chris Verslype, Olivier Rosmorduc, P. Rougier

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets

    Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets by Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos van Pelt

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Review article: non‐biological liver support in liver failure

    Review article: non‐biological liver support in liver failure by Wim Laleman, Alexander Wilmer, Pieter Evenepoel, Chris Verslype, Johan Fevery, Frederik Nevens

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Sorafenib: from literature to clinical practice

    Sorafenib: from literature to clinical practice by V. Di Marco, F. De Vita, John Koskinas, David Semela, Pierluigi Toniutto, Chris Verslype

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Applications of single-cell multi-omics in liver cancer

    Applications of single-cell multi-omics in liver cancer by Frederik Peeters, Sarah Cappuyns, Marta Piqué‐Gili, Gino Phillips, Chris Verslype, Diether Lambrechts, Jeroen Dekervel

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response

    Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response by Jeroen Dekervel, Ashenafi Bulle, Petra Windmolders, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, Jos van Pelt

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Review article: blood platelet number and function in chronic liver disease and cirrhosis

    Review article: blood platelet number and function in chronic liver disease and cirrhosis by Peter Witters, Kathleen Freson, Chris Verslype, K. Peerlinck, Marc Hoylaerts, Frederik Nevens, Chris Van Geet, David Cassiman

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    <sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use

    <sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use by Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, Christophe M. Deroose

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.

    Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver fail... by Wim Laleman, Alexander Wilmer, Pieter Evenepoel, Ingrid Vander Elst, Marcel Zeegers, Zahur Zaman, Chris Verslype, Johan Fevery, Frederik Nevens

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions

    Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions by Wim Laleman, Len Verbeke, Philippe Meersseman, Joost Wauters, Jos van Pelt, David Cassiman, Alexander Wilmer, Chris Verslype, Frederik Nevens

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

    A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma by Hannah van Malenstein, Geert Maleux, Vincent Vandecaveye, Sam Heye, Wim Laleman, Jos van Pelt, Johan Vaninbroukx, Frederik Nevens, Chris Verslype

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease

    Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease by Tania Roskams, Shi Qi Yang, Aymen Koteish, Anne Durnez, R Devos, Xiawen Huang, Ruth Achten, Chris Verslype, Anna Mae Diehl

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series

    Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series by Barbara Willandt, Janneke G. Langendonk, Katharina Biermann, Wouter Meersseman, F D’Heygere, C. George, Chris Verslype, Diethard Monbaliu, David Cassiman

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies

    Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies by Niloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel, Kristof Baete, Kristiaan Nackaerts, Paul M. Clément, Eric Van Cutsem, Chris Verslype, Christophe M. Deroose

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease

    Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease by Peter Witters, K. De Boeck, Lieven Dupont, Marijke Proesmans, F. Vermeulen, R Servaes, Chris Verslype, Wim Laleman, Frederik Nevens, Ilse Hoffman, David Cassiman

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

    Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer by David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, D. Bets, M. Mueser, A. Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma

    A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma by Hannah van Malenstein, Olivier Gevaert, Louis Libbrecht, Anneleen Daemen, Joke Allemeersch, Frederik Nevens, Eric Van Cutsem, David Cassiman, Bart De Moor, Chris Verslype, Jos van Pelt

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

    YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role by Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

    Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial by Marianna Alunni‐Fabbroni, Kerstin Rönsch, Thomas S. Huber, Clemens C. Cyran, Max Seidensticker, Julia Mayerle, Maciej Pech, Bristi Basu, Chris Verslype, Julia Benckert, Peter Malfertheiner, Jens Ricke

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

    Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer by Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna, Yves Humblet, Sharlene Gill, Jean‐Luc Van Laethem, Chris Verslype, Werner Scheithauer, Aijing Shang, Jan Cosaert, Malcolm J. Moore

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: